We used piroxicam, which has no effect on wild-type mice, to accelerate/synchronize the development of colitis in IL-10-/- mice [31,32,33] and naloxone-methiodide, a general opioid receptor antagonist that does not cross the blood-brain barrier to neutralize opioid receptors in the periphery. Here, IL10 is linked to colitis.